article thumbnail

San Diego Life Sciences Roundup: MedCrypt, LunaDNA, Dynacure & More

Xconomy

Let’s catch up with the latest life sciences news in San Diego. The company says it will use the new funds to hire new salespeople and engineers and further develop its technology, which medical devices vendors use to secure data traveling between or stored on devices. million Series A funding round.

article thumbnail

San Diego Life Sciences Roundup: MEI Pharma, Turning Point, & More

Xconomy

It was a relatively quiet week in the San Diego life sciences community, but local companies and organizations continue working away. —MEI Pharma, a late-stage cancer drug developer, presented updated data from a Phase 1b study of its lead drug candidate, ME-401, which is designed to inhibit a molecular pathway called PI3K delta.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

MatriSys Bioscience Finds $1.5M From Tech Coast Angels

socalTECH

San Diego-based MatriSys Bioscience , which is developing treatments for treating skin and dermatologic conditions, says it has raised $1.5M The company's technology is based on skin microbiome research developed at the University of San Diego, in the labs of Professor Richard Gallo. READ MORE>>.

article thumbnail

As Alzheimer’s Conference Kicks Off, All Eyes Are on Biogen’s Drug

Xconomy

It’s the “era of neuroscience”; an industry “turning point”; and “an amazing time”—superlatives were flowing freely as the 11th annual Clinical Trials on Alzheimer’s Disease Congress (CTAD) kicked off in rainy San Diego late Wednesday afternoon. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

article thumbnail

CommNexus and The Industry Leaders SIG Presents. Being Grid Smart

SoCal Tech Calendar

Wednesday, February 17, 2010 -- CommNexus and The Industry Leaders SIG Presents. Are San Diego companies involved? Join us on February 17, 2010 as a diverse panel of industry players shares their views on the development, growth, challenges, and opportunities in this rapidly evolving market. Being Grid Smart.

San Diego 100
article thumbnail

Retrophin Sinks as Drug “Pharma Bro” Martin Shkreli Co-Invented Fails

Xconomy

Retrophin, the drug developer founded by jailed former biotech executive Martin Shkreli, has failed its first big test. The San Diego-based company’s experimental drug fosmetpantotenate failed a Phase 3 trial, FORT, in patients with a rare and deadly neurological disorder called pantothenate kinase-associated neurodegeneration, or PKAN.

article thumbnail

Sundae snags $36M to build out its distressed property marketplace

TechCrunch LA

He did note that in the four markets where the company has gone live since launching its business in January 2019 — San Diego, Los Angeles, the Inland Empire , and Sacramento — has yielded an annualized revenue run rate of over $400 million in gross merchandise value (the total value of home sales transacted on its platform).

Sales 282